GlassScriptPhysician profile
Eric S Gwynn
NPI 1467586628
$18,770.47
in general payments reported to CMS, 2019-2025
25 companies · $1,434 in 2025
The $1,434 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $486 · 2021: $595 · 2022: $1,761 · 2023: $847 · 2024: $291 · 2025: $1,434.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,948 · Travel and Lodging: $590 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,948.12 |
| Travel and Lodging | $589.84 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $12,692.86 | 2019 | |
| Coloplast Corp | $2,287.35 | 2019-2025 | Restorelle, Titan, Supris |
| Medtronic, INC. | $1,357.43 | 2021-2025 | Interstim, Altaviva |
| Olympus America INC. | $634.93 | 2021-2025 | Itind System |
| Neotract INC. | $399.49 | 2019-2020 | |
| Palette Life Sciences, INC. | $232.73 | 2022 | |
| Medtronic USA, INC. | $165.39 | 2019-2020 | |
| Pfizer INC. | $131.08 | 2019-2025 | |
| Boston Scientific Corporation | $125.74 | 2022-2025 | Spaceoar Vue System - 10ml |
| Teleflex LLC | $116.61 | 2022 | |
| Ambu INC. | $93.84 | 2022 | |
| Sumitomo Pharma America, INC. | $58.17 | 2025 | Gemtesa, Orgovyx |
| Axonics, INC. | $57.63 | 2022-2024 | Axonics |
| Blue Earth Diagnostics | $57.26 | 2022 | |
| Merck Sharp & Dohme LLC | $54.43 | 2024-2025 | Keytruda |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $50.59 | 2025 | |
| Endo USA, INC. | $46.02 | 2024-2025 | Xiaflex |
| Organogenesis INC. | $39.53 | 2025 | Puraply Wound Matrix |
| Urogen Pharma, INC. | $37.73 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| Tolmar, INC. | $27.57 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.52 | 2025 | |
| Calyxo, INC. | $20.70 | 2025 | Cvac Aspiration System |
| Ethicon US, LLC | $13.34 | 2020 | |
| Intuitive Surgical, INC. | $11.47 | 2023 | Da Vinci Surgical System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Gwynn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.